Key terms
About SCTL
Societal CDMO, Inc. is a bi-coastal CDMO with capabilities spanning pre-investigational new drug (IND) development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a focus on small molecules. With expertise in solving complex problems, the company provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill and finish, lyophilization, packaging, and logistics services to the pharmaceutical market. The company was founded in 2007. It has sites in Gainesville, GA, San Diego, CA, and is headquartered in Exton, PA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SCTL news
Mar 24
2:01am ET
Societal Cdmo at the Crossroads: Merger with CoreRx Faces Uncertain Future and Financial Risks
Feb 29
9:25am ET
Societal CDMO (SCTL) Receives a Buy from Craig-Hallum
Feb 29
7:17am ET
Societal CDMO downgraded to Market Perform from Outperform at William Blair
Feb 29
6:26am ET
Societal CDMO downgraded to Equal Weight from Overweight at Stephens
Feb 29
4:52am ET
Societal CDMO downgraded to Sector Perform from Outperform at RBC Capital
Feb 28
5:23pm ET
Societal CDMO’s Merger and Tender Offer by CoreRx
Feb 28
5:20pm ET
Societal CDMO to be acquired by CoreRx for $1.10 per share in cash
Feb 28
5:00pm ET
Societal CDMO trading resumes
Feb 28
4:21pm ET
Societal CDMO trading halted, news pending
Feb 01
9:10am ET
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Societal CDMO (SCTL)
Feb 01
7:23am ET
Societal CDMO, Benuvia sign co-marketing agreement to promote CDMO, API
No recent news articles are available for SCTL
No recent press releases are available for SCTL
SCTL Financials
Key terms
Ad Feedback
SCTL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SCTL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range